definitely massive gap between the ears of those selling... don’t think it will be filled.
As a first step, a couple of counties in Hunan China are about to get fitted out with Aspirals as part of a high profile (both nationally and internationally) Yangtze River Protection Program managed by the Three Gorges.
I don’t know how quickly this will ramp up, but if I were Three Gorges I’d be using this as a test of Fluence’s ability to execute a reasonably sized installation of 29 units. Or it could even be that Fluence have given Three Gorges a timeline of how quickly it can execute a full fit out of the 11 provinces within their mandate.
Either way this first order will give Fluence the confidence to ramp up production and its teams in order to meet future demand which may very quickly be a case of capacity constraint on Fluence’s side. We’ve seen signs of them hiring in the past few months... I think they are going to go even harder on that front now.
But with Richard’s new focused strategy of SPS, I feel Fluence is more able to handle a demand surge. There are no distractions and funds being pulled into competing divisions... this is their core business now and it’s starting to bear fruit.
But there are always going to be short term traders... but I don’t understand any long term shareholders / or those looking to be long term shareholders selling out anywhere near these levels... It’s like leaving a party when the music just started playing...
Add to My Watchlist
What is My Watchlist?
